QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES
associated with 47 other trademarks
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous s...

Words that describe this trademark:

central nervous system  peripheral nervous system  nervous system peripheral  treatment prevention  system peripheral  pharmaceutical preparations  humans  preparations  prevention  therapeutic 

Serial Number:

90287732

Mark:

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

Status:

Abandoned-No Statement of Use filed

Status Date:

08-29-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine

Mark Description:

The mark consists of The horizontally-situated word "QELBREE" with a diamond shape above and to the right of the last "E" of "QELBREE"; the word "VILOXAZINE" positioned underneath the word "QELBREE"; and the phrase "EXTENDED-RELEASE CAPSULES" positioned underneath the word "VILOXAZINE".

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

06-01-2021

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

08-29-2022

Business Name:

SAUL EWING ARNSTEIN & LEHR

Correspondent Name:

Recent Trademark filings by this company